Jump to content

Draft:Natalia Bellan

From Wikipedia, the free encyclopedia
  • Comment: The citations are mostly written by the subject or are not in depth (e.g. stating that she will speak at an event). Some whole paragraphs are unreferenced. Also, I'm afraid I found several parts of the article unclear, e.g. what is a line of Professional Research? Mgp28 (talk) 08:25, 3 August 2024 (UTC)

Natalia Bellan
Born (1985-07-16) July 16, 1985 (age 39)

Natália Bellan (born July 16, 1985, in Mooca, São Paulo) is an Italian-Brazilian executive, scientist, speaker and writer.

Life

[edit]

Her family is essentially originally from Italy, her mother from the Lazio region and her father from the Veneto region and some with Austrian ancestry.[1] Bellan speaks Portuguese, Spanish, Italian and English, and has worked and lived in several countries such as Spain, Italy, Switzerland, Malta, the United Kingdom and Brazil.

She graduated in Civil Engineering Technician from the Federal Institute of Science and Technology, Pharmacy & Biochemistry from the Universidade Estadual Paulista in Brazil and the University of Santiago de Compostela in Spain. Master's and Doctorate (Strictu Sensu) from the University of São Paulo.

She created a line of Professional Research applied to the pharmaceutical industry and regulatory agencies in compliance with international regulatory requirements (Research officially deposited in 2011). It has trained more than 3,000 postgraduate/MBA (latu sensu) professionals in the regulatory area over the last 20 years in different countries and languages. She has supervised the course completion work of more than 20 students.[2]

She began her research and work in the area in mid-2005, and was one of the youngest women to obtain a doctorate[citation needed] (2016) with a master's degree from the University of São Paulo. At the same time that he managed several projects in the pharmaceutical industry, taught classes, and wrote articles and books to build the "New Science - Regulatory Intelligence with Strategy of Business" in the most regulated and complex sector in the world.

As there was still no research or scientific publications in the area, she developed her studies with the more complex classes of products, which are medicines and medical devices. Currently, his courses, books and articles have been recommended to students studying pharmaceutical sciences and postgraduate courses in different countries.[3][4][5][6][7][8][9][10][11]

In 2010 she founded Sanitary Intelligence International, which specializes in complex and innovative projects, especially in the area of biotechnology, biological medicines, rare diseases, oncology , medical devices, software such as medical devices, and robotic surgery.

References

[edit]
  1. ^ "Berlim Germany". Research Gate. Retrieved 2024-05-04.
  2. ^ "National Council for Scientific and Technological Development, accessed on 04/05/2024".
  3. ^ Bellan N, de J.A.P. T. Sanitary regulation of medicines in Brazil. 1 ed. São Paulo: Editora Manole, 2015. 480 p. ISBN 8520439675.
  4. ^ Bellan, Natália (2016). Bellan N. Regulatory guidelines applicable to the chain of medical devices (MDR/SAMD/MedTech). PhD thesis, University of São Paulo, Brazil, 2016 (Thesis). Universidade de São Paulo. doi:10.11606/T.9.2016.tde-20062016-153219.
  5. ^ Bellan, Natalia (2013). Guidelines for the sanitary registration process of medicines (Master's Dissertation). University of São Paulo. doi:10.11606/D.9.2013.tde-30072015-100420 – via www.teses.usp.br.
  6. ^ Rodríguez, Guillermo (2024-02-19). "Inteligencia regulatoria: la clave del éxito en la industria farmacéutica moderna" [Regulatory intelligence: the key to success in the modern pharmaceutical industry]. www.farmaindustrial.com. Retrieved 2024-05-05.
  7. ^ Bellan N. Civil responsibility of the pharmacist in the productive chain of medicinal products. 2016. Poster session presented at 7º Simpósio Brasileiro de Vigilância Sanitária, Salvador, Brazil.
  8. ^ "Associación Española de los Farmacéuticos en España". Associación Española de los Farmacéuticos en España. 2 February 2022. Retrieved 2024-05-04.
  9. ^ "Introducción a la FDA, aula ministrada em 2021 na AEFI". December 2021.
  10. ^ "Berlim, Alemanha". Research Gate.
  11. ^ "USA". RAPS. Retrieved 2024-05-04.